AzTrials
AzTrials

Clavicle FractureScanDiLaCNCT06981065

The Scandinavian Displaced Lateral Clavicle Trial

A study testing Simple Sling and Physiotherapy and Surgical treatment in people with Clavicle Fracture, run by Uppsala University at 11 sites in 4 countries.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

A multicentre multinational RCT to investigate whether non-surgical treatment is non-inferior to surgical treatment for displaced extraarticular lateral clavicle fractures in adults. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Clavicle Fracture
What is being tested?
Simple Sling and Physiotherapy and Surgical treatment
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
96 participants
Where
11 sitesin 4 countries
Study dates
17 Sep 2025to 31 Dec 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Displaced extraarticular lateral clavicle fracture (type II or V according to the modified Neer classification)

Who cannot join

  • Pathological fracture
  • Open fracture
  • Neurovascular injury
  • Same-time fracture in the upper extremity
  • Polytrauma
  • Contraindications to surgery and/or anesthesia
  • Unable to give informed consent
  • Inability to complete follow-up

Trial locations and contacts

11 sites in 4 countries. Contact the study team or a site near you to ask about taking part.

Pontus Christersson, MD, PhD Student contact

+46-18-6110000

pontus.christersson@uu.se

11 sites in 4 countries

Sweden8 sites, 8 recruiting
  • Kalmar Regional Hospital

    Kalmar

    Mats Ranbebo, +46103580000, mats.ranebo@regionkalmar.se

    Recruiting
  • Linköping University Hospital

    Linköping

    Johan Scheer, +46-10-1030000, johan.scheer@regionostergotland.se

    Recruiting
  • Skane University Hospital

    Malmö

    Jonas Nordin, +46-40-331000, jonas.nordin@skane.se

    Recruiting
  • Örebro University Hospital

    Örebro

    Per Fischer, +46-19-6021000, per.fischer@regionorebrolan.se

    Recruiting
  • Danderyd Hospital

    Stockholm

    Viktor Mili-Schmidt, +46-8-12355000, viktor.schmidt@ki.se

    Recruiting
  • Stockholm South Hospital

    Stockholm

    Johanna Rundgren, +46812361000, johanna.rundgren@regionstockholm.se

    Recruiting
  • Norrlands University Hospital

    Umeå

    Jonas Sundkvist, +46-90-7850000, jonas.sundkvist@umu.se

    Recruiting
  • Uppsala University Hopsital

    Uppsala

    Pontus Christersson, +46-18-6110000, pontus.christersson@uu.se

    Recruiting

Other trials in Sweden

Denmark1 site, 1 recruiting
  • Odense University Hospital

    Odense

    Bjarke Viberg, bjarke.viberg@rsyd.dk

    Not yet recruiting

Other trials in Denmark

Finland1 site, 1 recruiting
  • Tampere University Hospital

    Tampere

    Antti Launonen, antti.launonen@loosi.ee

    Not yet recruiting

Other trials in Finland

Norway1 site, 1 recruiting
  • Østfold Hospital Trust

    Fredrikstad

    Frede Frihagen, ffrihagen@gmail.com

    Not yet recruiting

Other trials in Norway

About this study

Official title: The Scandinavian Displaced Lateral Clavicle Trial (ScanDiLaC) - A Multicentre, Pragmatic, 12-Month, Non-inferiority, Randomized Controlled Trial

A multicentre multinational RCT to investigate whether non-surgical treatment is non-inferior to surgical treatment for displaced extraarticular lateral clavicle fractures in adults.

Read the detailed description

The aim of this study is to investigate whether non-surgical treatment is non inferior to surgical treatment for displaced lateral clavicle fractures with regards to functional outcome measured with different patient-reported outcome measures. Patients aged 18-65 years will be randomized to non-surgical or surgical (pragmatic) treatment. The primary outcome is the Disabilities of Arm Hand and Shoulder (DASH) score at 1 year.

Being tested
Simple Sling and Physiotherapy, Surgical treatment
Keywords
Displaced lateral clavicle fracture, Non-surgical, Surgical, PROMs, Health economy, Non-inferior, Complications

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Simple Sling and PhysiotherapyProcedure or surgery

    Non-surgical treatment with a simple sling and physiotherapy according to standardized program.

  • Surgical treatmentProcedure or surgery

    Surgical treatment with plate and screws (lateral clavicle plate, clavicle plate or hook plate with/without coracoclavicular fixation).

Study groups in NCT06981065
Study groupRoleWhat they receive
Non-surgicalExperimentalNon-surgical treatment with a simple sling and physiotherapy. Cross-over option at 6 weeks if signs of symptomatic delayed union, non-decreasing pain, and patient requests surgery
Receives: Procedure: Simple Sling and Physiotherapy
SurgicalActive comparatorSurgical treatment with plate and screws
Receives: Procedure: Surgical treatment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Disabilites of the Arm, Shoulder and Hand (DASH)

    A 30-item patient-reported outcome measure concerning shoulder, arm and hand function, with two additional 4-item modules concerning work and sports function.

    Min: 0 Max: 100. 0 representing no disability and 100 representing the most severe disability. A DASH score of 50 or more is often considered a cutoff for the presence of severe disability, while 20 or more suggests a medium level of disability.

    Measured: 1 year

Secondary outcomes (5)
  1. Disabilites of the Arm, Shoulder and Hand (DASH)

    A 30-item patient-reported outcome measure concerning shoulder, arm and hand function, with two additional 4-item modules concerning work and sports function.

    Min: 0 Max: 100 0 representing no disability and 100 representing the most severe disability. A DASH score of 50 or more is often considered a cutoff for the presence of severe disability, while 20 or more suggests a medium level of disability.

    Measured: Pre-injury, 6 weeks, 3 months, 6 months, 2 years, 5 years

  2. Nottingham Clavicle Score (NCS)

    A 10-item disease-specific PROM concerning functional outcome after injuries and diseases around the clavicle.

    The minimum possible score is 20, and the maximum is 100. A higher score indicates better functional ability, while a lower score suggests greater functional disability. The NCS can be graded as excellent (80-100), good (60-79), fair (40-59), or poor (<40).

    Measured: 6 weeks, 3 months, 6 months, 1, 2, 5 years

  3. University of California, Los Angeles (UCLA) Activity scale

    An activity scale measured in 10 levels. It ranges from 1 to 10, with 1 representing no physical activity and 10 representing regular participation in impact sports.

    Measured: Pre-injury, 6 weeks, 3 months, 6 months, 1 years

  4. EuroQol 5-Dimension 5-Level (EQ-5D-5L) questionnaire

    Health-Related Quality of Life (HRQoL) measured in 5 Levels. The minimum and maximum possible outcomes for EQ-5D-5L index scores are -0.573 and 1, respectively. The minimum value represents a health state considered worse than death, while 1 represents full health.

    Measured: Pre-injury, 6 weeks, 3 months, 6 months, 1, 2, 5 years

  5. Visual Analog Scale (VAS) for pain

    Pain measure by visual analog scale in 11 levels. Minimum 0 and maximum 10. Higher figure indicates more pain. 10 is maximum pain.

    Measured: Baseline, 6 weeks, 3 months, 6 months, 1, 2, 5 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 May 2025
  2. Study start17 Sep 2025
  3. Primary completion31 Dec 2028 (estimated)
  4. Study completion31 Dec 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Parallell with cross-over option in non-surgical arm
Masking
None (open label)
Enrolment
96 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06981065
Sponsor's protocol ID
2025-01097-01
Other IDs
2025
Acronym
ScanDiLaC
Status last verified
Dec 2025
First submitted
12 May 2025
Last updated
10 Dec 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Christersson P, Karimi D, Gronhaug K, Launonen A, Brorson S, Frihagen F, Viberg B, Hailer N, Wolf O. The Scandinavian Displaced Lateral Clavicle trial (ScanDiLaC): a study protocol for a randomized clinical trial. Trials. 2026 Jun 13;27(1):438. doi: 10.1186/s13063-026-09844-8.

    PubMed 42288927

Questions about this trial

What is this clinical trial studying?

A study testing Simple Sling and Physiotherapy and Surgical treatment in people with Clavicle Fracture, run by Uppsala University at 11 sites in 4 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 10 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 11 sites in Sweden, Denmark, Finland, Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Pontus Christersson, MD, PhD Student (+46-18-6110000, pontus.christersson@uu.se), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Disabilites of the Arm, Shoulder and Hand (DASH) (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06981065, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Dec 2025; AzTrials last refreshed its copy on 2 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in